Search - tctmd.com

Displaying 1 - 20 of 95

Sort: Relevancy | Date

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Daily News

Heavy Alcohol Use Tied to More-Severe Intracerebral Hemorrhages

Todd Neale

November 06, 2025

News Daily News

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Michael O'Riordan

August 06, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Daily News

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Michael O'Riordan

June 25, 2025

News Daily News

PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits

Michael O'Riordan

December 18, 2024

News Daily News

Lp(a) Can Vary Over Time in ASCVD Patients With High Baseline Levels: OCEAN(a)-DOSE

Yael L. Maxwell

December 13, 2024

News Daily News

Teens Who Smoke Face Risk of Cardiac Damage by Their Mid-20s

Caitlin E. Cox

December 12, 2024

News Daily News

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

Yael L. Maxwell

November 27, 2024

News Daily News

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Michael O'Riordan

November 13, 2024

News Daily News

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

Michael O'Riordan

October 14, 2024

News Daily News

Statins Are Cost-effective in the Elderly

Michael O'Riordan

September 11, 2024

News Daily News

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Michael O'Riordan

July 29, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

Michael O'Riordan

June 21, 2024

News Daily News

FDA Approves Aprocitentan for Inadequately Controlled Hypertension

Michael O'Riordan

March 20, 2024

News Daily News

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Michael O'Riordan

February 27, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

News Daily News

PAD, AAA: High Lp(a) Portends Problems Beyond CVD

Caitlin E. Cox

December 06, 2023

News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Michael O'Riordan

December 06, 2023

Advertisement

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Heavy Alcohol Use Tied to More-Severe Intracerebral Hemorrhages

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits

Lp(a) Can Vary Over Time in ASCVD Patients With High Baseline Levels: OCEAN(a)-DOSE

Teens Who Smoke Face Risk of Cardiac Damage by Their Mid-20s

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

Statins Are Cost-effective in the Elderly

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

FDA Approves Aprocitentan for Inadequately Controlled Hypertension

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

PAD, AAA: High Lp(a) Portends Problems Beyond CVD

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content